Oliviero James F III's Form 4 filing
Checkpoint Therapeutics, Inc. (CKPT) · filed Dec 20, 2024
- Accession no.
- 0001104659-24-130963
- Filed
- Dec 20, 2024
- Trade date
- Dec 18-20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $3.07M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oliviero James F IIICIK 0001434718 | Director, Officer (CEO, President and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | COMMON STOCK | SSaleDisposed | −602,167 | $3.87F2 | −$2,330,386.29 | 3,414,813 | Direct | |
| Dec 19, 2024 | COMMON STOCK | SSaleDisposed | −220,230 | $3.38F4 | −$744,377.4 | 3,194,583 | Direct | |
| Dec 20, 2024 | COMMON STOCK | GGiftDisposed | −900,000 | $0.00 | $0 | 2,294,583 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.66 to $4.27. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $3.33 to $3.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.